MeiraGTx Holdings PLC
MGTX
NASDAQ
Biotechnology
$13.52
USD
+0.85 (+6.71%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.23B
Volume 809.2K
Revenue
$79.76M
TTM
+131.1%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-120.53M
TTM
+28.0%
YoY
Operating Cash Flow
$8.28M
TTM
+107.9%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 1.9 | 3.7 | 0.4 | 75.4 | 0.3 |
YoY Growth | +176.3% | +1208.9% | -96.2% | +252.3% | -84.8% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 1.9 | 3.7 | 0.4 | 75.4 | 0.3 |
Selling, General & Administrative | 10.7 | 15.0 | 13.9 | 18.1 | 9.1 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 43.5 | 48.5 | 46.5 | 48.9 | 41.1 |
Operating Income | -41.6 | -44.8 | -46.1 | 26.5 | -40.8 |
EBITDA | -38.5 | -41.6 | -42.9 | 29.6 | -37.8 |
Other Income / Expense | 3.7 | 8.6 | -1.6 | -8.6 | -2.8 |
Total Other Income / Expense | 1.6 | 6.0 | -4.5 | -11.4 | -5.5 |
Income Before Income Taxes | -40.0 | -38.8 | -50.5 | 15.1 | -46.3 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -40.0 | -38.8 | -50.5 | 15.1 | -46.3 |
Consolidated Net Income / Loss | -40.0 | -38.8 | -50.5 | 15.1 | -46.3 |
Net Income Attributable to Common Shareholders | -40.0 | -38.8 | -50.5 | 15.1 | -46.3 |
Basic EPS | -$0.51 | -$0.48 | -$0.62 | $0.19 | -$0.57 |
Diluted EPS | -$0.51 | -$0.48 | -$0.62 | $0.19 | -$0.57 |
Basic Shares Outstanding | 79.0M | 80.6M | 80.9M | 81.2M | 81.3M |
Diluted Shares Outstanding | 79.0M | 80.6M | 80.9M | 81.2M | 81.3M |